Dual-Peptide Recovery & Repair Support
The TB-500 + BPC-157 Combo brings together two extensively researched peptides known for their complementary roles in tissue repair and inflammatory response modulation. Each vial contains 5mg of TB-500 and 5mg of BPC-157, offering a streamlined solution for recovery-focused research protocols.
This combination is frequently studied in models investigating connective tissue regeneration, post-training recovery, soft tissue repair, and immune response balance.
Why This Combination?
- Accelerated Tissue Repair: Investigated for supporting regeneration of muscles, tendons, ligaments, and skin structures.
- Inflammation Modulation: Both peptides are studied for reducing inflammatory signaling and promoting recovery efficiency.
- Mobility & Flexibility Research: TB-500 is associated with actin regulation pathways that influence flexibility and tissue resilience.
- Gut Integrity Support: BPC-157 is widely researched for its role in maintaining and repairing intestinal lining integrity.
- Simplified Protocol Design: Two synergistic peptides in one vial reduce complexity in structured research models.
Research Highlights
- TB-500 (Thymosin Beta-4 fragment): Studied for promoting cell migration, angiogenesis signaling, and systemic tissue remodeling support.
- BPC-157: Explored for soft tissue repair, angiogenic pathways, gut healing models, and recovery from mechanical stress.
- Joint & Tendon Research: The combination is commonly evaluated in tendon, ligament, and joint repair models.
- Recovery Optimization: Frequently included in research programs aiming to reduce downtime and enhance structural recovery.
Product Specifications
- Concentration: TB-500 5mg + BPC-157 5mg per vial
- Physical Form: Sterile lyophilized powder
- Vial Type: Depyrogenated glass vial
- Stability: Freeze-dried for extended shelf life
- Closure: Butyl rubber stopper for multi-access integrity
- Sterility: ETO-sterilized, pyrogen-free
- Seal: Tamper-evident aluminum flip-top
Research-Reference Dosing Information
In research settings, protocols commonly explore 250–500 mcg of each peptide administered once or twice daily depending on the study objective. Short-term recovery-focused models may run 4–6 weeks, while maintenance-oriented research may utilize lower dosing strategies. Protocol structure varies based on the tissue model and injury parameters under investigation.
Research-Reference Safety Profile
Preclinical data suggests these peptides demonstrate favorable tolerability in research applications. Observations may include mild injection-site sensitivity or temporary irritation. Long-term human safety data remains under active investigation.
Consultation & Protocol Guidance
If you are designing a recovery-focused, connective tissue, or immune-modulated research protocol, our team can help guide product selection and combination strategies aligned with your objectives.
Important Notice: This compound is supplied strictly for laboratory research and analytical purposes only. Not for human consumption, medical use, or veterinary application.